TickerFactsScreenerDevelopers

Transcode Therapeutics, Inc. (RNAZ) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $828.0K2021: $20.83M2022: $4.97M2023: $2.77M2024: $5.81M2025: $17.81M$17.81M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$17.81M+206.5%
2024$5.81M+110.0%
2023$2.77M-44.3%
2022$4.97M-76.1%
2021$20.83M+2415.2%
2020$828.0K—